Bill > SB00150

This bill modifies existing law regarding the dispensing of medications used to treat Attention-deficit/hyperactivity Disorder (ADHD) by requiring pharmacists to dispense such medications only under specific conditions. Specifically, a pharmacist must dispense an ADHD medication if two conditions are met: first, the patient must have a valid prescription for the drug, and second, the patient must provide the pharmacist with a quantitative electroencephalogram (qEEG) brain map. A qEEG is a diagnostic tool that measures electrical activity in the brain, creating a visual "map" of brain wave patterns, which in this context is intended to potentially help verify or support the ADHD diagnosis. The bill aims to add an additional layer of medical documentation and verification before ADHD medications can be dispensed, potentially to ensure more precise diagnosis and medication management.

Justice

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00150&which_year=2025